← Back to Search

Procedure

Intraspinal Pressure Monitoring for Spinal Cord Injury

N/A
Recruiting
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
• patients with acute traumatic spinal cord injury ASIA A, B or C
age between 18-70yrs
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial will help validate a new technique for measuring pressure and perfusion in the spine after injury, which could help improve outcomes for patients with spinal cord injuries.

Who is the study for?
This trial is for individuals aged 18-70 who have recently suffered a traumatic spinal cord injury classified as ASIA A, B, or C. It's not specified who can't join the trial.
What is being tested?
The study tests inserting a fiberoptic pressure monitor into the spine to measure pressure and blood flow after an injury. The goal is to find optimal conditions for spinal health during ICU recovery.
What are the potential side effects?
While specific side effects are not detailed, monitoring involves invasive procedures that may carry risks such as infection, bleeding, or additional spinal damage.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My spinal cord injury is classified as severe to moderate (ASIA A, B, or C).
Select...
I am between 18 and 70 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Derivation of parameters for optimal spinal cord perfusion pressure using intraspinal pressure data
Secondary study objectives
Record rates of adverse events in patients having insertion of intraspinal pressure monitor

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intraspinal Pressure MonitoringExperimental Treatment1 Intervention
A fiberoptic pressure monitoring device will be placed into the subarachnoid space at the site of traumatic spinal cord injury

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
621 Previous Clinical Trials
206,543 Total Patients Enrolled
Health Sciences Centre Foundation, ManitobaOTHER
15 Previous Clinical Trials
9,313 Total Patients Enrolled
~3 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top